192 related articles for article (PubMed ID: 27207427)
1. A possible new role for Aβ in vascular and inflammatory dysfunction in Alzheimer's disease.
Zamolodchikov D; Strickland S
Thromb Res; 2016 May; 141 Suppl 2():S59-61. PubMed ID: 27207427
[TBL] [Abstract][Full Text] [Related]
2. The Alzheimer's disease peptide β-amyloid promotes thrombin generation through activation of coagulation factor XII.
Zamolodchikov D; Renné T; Strickland S
J Thromb Haemost; 2016 May; 14(5):995-1007. PubMed ID: 26613657
[TBL] [Abstract][Full Text] [Related]
3. Interactions of β-amyloid peptide with fibrinogen and coagulation factor XII may contribute to Alzheimer's disease.
Ahn HJ; Chen ZL; Zamolodchikov D; Norris EH; Strickland S
Curr Opin Hematol; 2017 Sep; 24(5):427-431. PubMed ID: 28661939
[TBL] [Abstract][Full Text] [Related]
4. A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease.
Chen ZL; Singh PK; Calvano M; Norris EH; Strickland S
Proc Natl Acad Sci U S A; 2023 Sep; 120(36):e2309389120. PubMed ID: 37639602
[TBL] [Abstract][Full Text] [Related]
5. Neuroinflammation in Alzheimer's Disease: The Preventive and Therapeutic Potential of Polyphenolic Nutraceuticals.
Sawikr Y; Yarla NS; Peluso I; Kamal MA; Aliev G; Bishayee A
Adv Protein Chem Struct Biol; 2017; 108():33-57. PubMed ID: 28427563
[TBL] [Abstract][Full Text] [Related]
6. Fibrin deposited in the Alzheimer's disease brain promotes neuronal degeneration.
Cortes-Canteli M; Mattei L; Richards AT; Norris EH; Strickland S
Neurobiol Aging; 2015 Feb; 36(2):608-17. PubMed ID: 25475538
[TBL] [Abstract][Full Text] [Related]
7. Activation of the factor XII-driven contact system in Alzheimer's disease patient and mouse model plasma.
Zamolodchikov D; Chen ZL; Conti BA; Renné T; Strickland S
Proc Natl Acad Sci U S A; 2015 Mar; 112(13):4068-73. PubMed ID: 25775543
[TBL] [Abstract][Full Text] [Related]
8. Fibrinogen and altered hemostasis in Alzheimer's disease.
Cortes-Canteli M; Zamolodchikov D; Ahn HJ; Strickland S; Norris EH
J Alzheimers Dis; 2012; 32(3):599-608. PubMed ID: 22869464
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen and beta-amyloid association alters thrombosis and fibrinolysis: a possible contributing factor to Alzheimer's disease.
Cortes-Canteli M; Paul J; Norris EH; Bronstein R; Ahn HJ; Zamolodchikov D; Bhuvanendran S; Fenz KM; Strickland S
Neuron; 2010 Jun; 66(5):695-709. PubMed ID: 20547128
[TBL] [Abstract][Full Text] [Related]
10. Focal inflammation in the brain: role in Alzheimer's disease.
Cooper NR; Bradt BM; O'Barr S; Yu JX
Immunol Res; 2000; 21(2-3):159-65. PubMed ID: 10852113
[TBL] [Abstract][Full Text] [Related]
11. Does a pro-inflammatory process precede Alzheimer's disease and mild cognitive impairment?
Ferretti MT; Cuello AC
Curr Alzheimer Res; 2011 Mar; 8(2):164-74. PubMed ID: 21345170
[TBL] [Abstract][Full Text] [Related]
12. β-Amyloid Orchestrates Factor XII and Platelet Activation Leading to Endothelial Dysfunction and Abnormal Fibrinolysis in Alzheimer Disease.
García-Mejía KA; Custodio-Chablé SJ; Vázquez-Franco JE; Reyes-Maldonado E; Lezama RA
Alzheimer Dis Assoc Disord; 2021 Jan-Mar 01; 35(1):91-97. PubMed ID: 33629978
[TBL] [Abstract][Full Text] [Related]
13. Activation of complement and contact system in Alzheimer's disease.
Bergamaschini L; Donarini C; Gobbo G; Parnetti L; Gallai V
Mech Ageing Dev; 2001 Nov; 122(16):1971-83. PubMed ID: 11589915
[TBL] [Abstract][Full Text] [Related]
14. Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors.
Salminen A; Ojala J; Kauppinen A; Kaarniranta K; Suuronen T
Prog Neurobiol; 2009 Feb; 87(3):181-94. PubMed ID: 19388207
[TBL] [Abstract][Full Text] [Related]
15. Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.
Boncoraglio GB; Piazza F; Savoiardo M; Farina L; DiFrancesco JC; Prioni S; Tagliavini F; Parati EA; Giaccone G
J Alzheimers Dis; 2015; 45(2):363-7. PubMed ID: 25537009
[TBL] [Abstract][Full Text] [Related]
16. Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.
Söllvander S; Ekholm-Pettersson F; Brundin RM; Westman G; Kilander L; Paulie S; Lannfelt L; Sehlin D
J Alzheimers Dis; 2015; 48(1):63-72. PubMed ID: 26401929
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapeutic approaches for Alzheimer's disease.
Wisniewski T; Goñi F
Neuron; 2015 Mar; 85(6):1162-76. PubMed ID: 25789753
[TBL] [Abstract][Full Text] [Related]
18. Innate immune system and inflammation in Alzheimer's disease: from pathogenesis to treatment.
Serpente M; Bonsi R; Scarpini E; Galimberti D
Neuroimmunomodulation; 2014; 21(2-3):79-87. PubMed ID: 24557039
[TBL] [Abstract][Full Text] [Related]
19. Co-immunization with DNA and protein mixture: a safe and efficacious immunotherapeutic strategy for Alzheimer's disease in PDAPP mice.
Liu S; Shi D; Wang HC; Yu YZ; Xu Q; Sun ZW
Sci Rep; 2015 Jan; 5():7771. PubMed ID: 25586780
[TBL] [Abstract][Full Text] [Related]
20. When astrocytes become harmful: functional and inflammatory responses that contribute to Alzheimer's disease.
Avila-Muñoz E; Arias C
Ageing Res Rev; 2014 Nov; 18():29-40. PubMed ID: 25078115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
